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ABSTRACT 
Estimation methods for nonlinear mixed-effects modelling have considerably improved 
over the last decades. Nowadays several algorithms implemented in different softwares are 
used. The present study aimed at comparing their performance for dose-response models. 
Eight scenarios were considered using a sigmoid Emax model, with varying sigmoidicity 
factors and residual error models. 100 simulated datasets for each scenario were generated. 
100 individuals with observations at 4 doses constituted the rich design and at 2 doses for the 
sparse design. Nine parametric approaches for maximum likelihood estimation were studied: 
FOCE in NONMEM and R, LAPLACE in NONMEM and SAS, adaptive Gaussian 
quadrature (AGQ) in SAS, and SAEM in NONMEM and MONOLIX (both SAEM 
approaches with default and modified settings). All approaches started first from initial 
estimates set to the true values, and second using altered values. Results were examined 
through relative root mean squared error (RRMSE) of the estimates. 
With true initial conditions, full completion rate was obtained with all approaches except 
FOCE in R. Runtimes were shortest with FOCE and LAPLACE, and longest with AGQ. 
Under the rich design with true initial conditions, all approaches performed well except FOCE 
in R. When starting from altered initial conditions, AGQ, and then FOCE in NONMEM, 
LAPLACE in SAS, and SAEM in NONMEM and MONOLIX with tuned settings, 
consistently displayed lower RRMSE than the other approaches. 
For standard dose-response models analyzed through mixed-effects models, differences 
could be identified in the performance of estimation methods available in current software. 
KEYWORDS 
MAXIMUM LIKELIHOOD ESTIMATION, FOCE, LAPLACE, ADAPTIVE GAUSSIAN 
QUADRATURE, SAEM 
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INTRODUCTION 
Non-linear mixed-effects models (NLMEM) were introduced to the biomedical field about 
30 years ago (1-3) and have substantially improved the information learned from preclinical 
and clinical trials. Within drug development, NLMEM were initially used for 
pharmacokinetic (PK) analyses (4), before being extended to pharmacokinetic-
pharmacodynamic (PKPD) analyses (5), along with dose-response analyses. On top of the 
structural mathematical model fit to PK or/and PD observations, the statistical model 
components enable the modeller to characterize results obtained in a set of individuals with 
the same parametric model and, in addition, to estimate the interindividual variability (6), and 
to quantify the unexplained variability (7). 
The estimation of the fixed effect and random effect parameters involve complex 
estimation methods. Maximum likelihood estimation (MLE) approaches constitute a large 
family of methods commonly used in NLMEM analyses (8). The non-linearity of the 
regression function in the random effects prevents a closed form solution to the integration 
over the random effects of the likelihood function (9), thus several algorithms have been 
developed for MLE. Gaussian assumptions for the distribution of the random effects are 
common among MLE methods, and form the group of parametric approaches (10). 
Along with methodological developments, different software have emerged, the most 
commonly used one (11) being NONMEM (12). Estimation algorithms available were first 
restricted to First-Order (FO) and then First-Order Conditional Estimation (FOCE), which 
were subsequently implemented in Splus, R and WinNonMix. LAPLACE (13) then appeared 
in NONMEM, while SAS witnessed the addition of two macros MIXLIN and NLINMIX. A 
later procedure in SAS that represented a considerable improvement was NLMIXED, with FO 
and adaptive Gaussian quadrature (AGQ). Alternatives followed with stochastic expectation 
maximisation (EM) algorithms, and especially the SAEM algorithm (14) implemented in the 
MONOLIX (15) and the NONMEM (16) software. 
Whilst the estimation algorithms use different statistical methods, all aim at producing 
reliable estimates of the model parameters. The complexity of the model and the 
approximations embedded in the algorithm could potentially lead to poor estimation 
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performance. This performance is measured through precision and accuracy. As the estimates 
may impact on clinical decisions and lead to biomedical conclusions, selecting an estimation 
method with lower bias and higher precision is desirable. 
In the past, several studies comparing algorithms have been performed, stimulated by the 
introduction of new algorithms (17, 18), as a systematic comparison from a workgroup (19), 
in order to highlight practical applications (20), or as a complex-problem solving survey (21). 
However, apart from (17, 18), these investigations were not supported by a high number of 
simulations, but rather considered the analysis of only one simulated dataset (19, 21) or one 
real dataset (20).  
Recently, large Monte Carlo simulation studies compared estimation methods performance 
for PD count (22, 23), categorical (24, 25), and repeated time-to-event (26) models, enlarging 
the challenge represented by the model type. Estimation methods compared over all these five 
investigations were LAPLACE in NONMEM, AGQ in SAS, SAEM in MONOLIX, SAEM in 
NONMEM and importance sampling in NONMEM. Nevertheless, rarely more than three 
approaches were compared within a study, although the panel of algorithms and software 
available to the modeller is now rich and diversified. A wider comparison has been performed 
for continuous PK data (27) and remained to be for dose-response analyses. 
The objectives of this study were to measure and compare the estimation performance of 
FOCE in NONMEM and R, LAPLACE in NONMEM and SAS, adaptive Gaussian 
quadrature in SAS, and SAEM in NONMEM and MONOLIX for a set of dose-response 
scenarios. 
METHODS 
1. Statistical model 
Let d = d1, …, dK be a set of ordered dose levels selected in a dose-response study and yik 
be the response of subject i = 1, …, N to the dose dk. The dose-response is assumed to be 
adequately described by a function f such as: 
ik k i ik
y f(d , ) ε      (1) 
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wherei is the p dimensional vector of the model individual parameters for subject i and ik 
is the measurement error. ik given i are assumed to be independent and normally distributed 
with a zero mean and a variance ik
2
 which can be additive (ik
2 
= 2) or proportional (k
2 
= 
f(dki

×2). f is a function than can be nonlinear with respect to the parameters  
i depend on the fixed effect p-dimensional vector  and the random effect q-dimensional 
vector i in the following manner when considering an exponential model to ensure 
positivity: 
iB η
i
μ e

      (2) 
with the random effects following a Gaussian distribution with a zero mean and a variance 
matrix  of size (q×q), whose diagonal elements are variances . The (p×q)-matrix B allows 
some components of not to have a random part. Also, the exponential random effect model 
ensures the positivity of the model parameter. 
Finally, let define the vector of all the model parameters as = (’,Vech()’,) where the 
operator Vech(.) creates a column vector from the matrix by stacking its lower diagonal 
elements below one another.  
2. Likelihood function 
The log-likelihood L(y;) is the sum over the N subjects of the individual likelihoods, 
L(yi;): 



N
1i
ii
);(yL)L(y;    (3) 
where the individual log-likelihood Li(yi ; ) is defined as follows: 
i i i i i i i
L (y ; ) log p(y , ; )d log p( y ; )p( ; )d
   
             
   
   (4) 
with p(yi|i ; ) the conditional density of the observations given the individual random 
effects, p(i ;) the density of the individual random effects, and p(yi, i ;) the likelihood 
of the ‘complete’ data which correspond to the observations plus the random effects, i.  
3. Estimation algorithms 
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Estimation methods are briefly described here. More details may be obtained in the original 
articles. 
3.1. First-Order Conditional Estimation (FOCE) 
As initially described by Lindstrom and Bates (28), the algorithm approximates (4) by the 
log-likelihood of a linear mixed effect model. The i and updated estimates of are obtained 
by minimizing a penalized nonlinear least square (PNLS) objective function using the current 
estimates of  and  Then, the model function f is linearized using a first-order Taylor 
expansion around the current estimates of  and the conditional mode of the i so that (4) can 
be approximated by the log-likelihood of a linear mixed effect (LME) model to estimate  
and . The maximization is realized through a hybrid approach starting with a moderate 
number of EM iterations before switching to Newton-Raphson iterations. The approach 
alternates between PNLS and LME until a convergence criterion is met. They implemented 
their method in the nlme function of the R software (29).  
In the NONMEM software, the conditional modes of the i are obtained by maximizing 
the empirical Bayes posterior density of i, p(i|yi ;), using the current estimates of vector 
: 
 



 )d;)p(;yp(
);)p(;yp(
;yp
iii
iii
ii
 (5) 
Also, (4) is approximated by a second order Taylor expansion of the integrand (also called 
Laplacian approximation) around the i ; however the Hessian is approximated by a function 
of the gradient vector to avoid the direct computation of second-order derivatives. For an 
additive residual error model, both the approximation by the linearization of the function f and 
the Laplacian approximation using an approximated Hessian have been shown to be 
equivalent asymptotically (9). However, this equivalence no longer holds in case of 
interaction between the i and the ik, as in the proportional error model. A derivative-free 
quasi-Newton type minimization algorithm is used. 
3.2. Laplacian approximation (LAPLACE) 
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The principle of this algorithm is to approximate (4) by a second order Taylor expansion of 
the integrand around the conditional mode of the i, which are obtained by maximizing the 
empirical Bayes posterior density of the i using the current estimates of vector . 
In the NLMIXED procedure of the SAS software (30), this algorithm is implemented as a 
special case of the adaptive Gaussian quadrature algorithm (see below) where only one 
abscissa is defined at the conditional modes of the i with a corresponding weight equal to 1. 
Also, the i are also obtained by maximizing p(i|yi;) with a default dual quasi-Newton 
optimisation method. 
3.3. Adaptive Gaussian Quadrature (AGQ) 
The principle of this algorithm is to numerically compute (4) by a weighted average of 
p(yi|i;) p(i;) at predetermined abscissa for the random effects using a Gaussian kernel. 
Pinheiro and Bates (31) suggested using standard Gauss-Hermite abscissa and weights (32), 
with the abscissa centred around the conditional mode of the i and scaled by the Hessian 
matrix from the conditional mode estimation (33). The adaptive Gaussian approximation can 
be made arbitrarily accurate by increasing the number of abscissa. 
3.4. Stochastic Approximation Expectation Maximization (SAEM) 
SAEM is an extension of the EM algorithm where individual random effects are 
considered as missing data (34). It converges to maximum likelihood estimates by repeatedly 
alternating between the E and M steps. As the E step is often analytically intractable for 
nonlinear models, the E step in SAEM is replaced by a simulation step where the i are drawn 
by running several iterations of a Hastings-Metropolis algorithm using three different kernels 
successively (35). Then the expectation of the complete log-likelihood 
Q() = E(log(p(y, η ))) is computed according to a stochastic approximation: 
       m m 1 m m m 1Q Q γ log p(y, ; ) Q          (6) 
where m is a decreasing sequence of positive numbers over the m = 1, …, M algorithm 
iterations with 1 = 1. The SAEM algorithm has been shown to converge to a maximum (local 
or global) of the likelihood of the observations under very general conditions (36).  
4. Simulation and estimation study 
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This simulation study consisted, for each studied scenario, of 100 stochastic simulated 
datasets generated in NONMEM and subsequently analysed with the different studied 
approaches (i.e. implementation of the estimation algorithms in the various software). 
4.1. Simulations 
4.1.1. Design 
The dataset structure mimicked a clinical trial including 100 individuals and investigating 
four dose levels: 0, 100, 300 and 1000 mg. A continuous PD outcome was recorded for each 
individual following two simulation designs: (i) the rich design counted four observations per 
individual, one at each dose level, whereas (ii) in the sparse design each individual was 
randomly allocated to only two of the four dose levels. 
4.1.2. Base model 
A dose-response model based on a sigmoid Emax function with a baseline (E0) was 
constructed as in (7). The Hill factor (γ) is responsible for the sigmoidicity, i.e. the degree of 
non-linearity of the function shape. 
i
i
i
max
i 0
50
E d
E E
ED d

 

 

  (7) 
Gaussian random components with normal zero-mean distribution were assumed for all 
individual parameters except for γ. A correlation in the variances of the random effects for 
Emax and ED50 was assumed. The residual error model was assumed to be additive or 
proportional (see 2.1). Selected parameters values are reported Table 1. 
4.1.3. Scenarios 
Eight simulation scenarios (s = 8) were derived, exploring (i) the two previously described 
simulation designs: rich (R) and sparse (S), (ii) three values of γ: 1, 2, and 3, and (iii) two 
error models: additive (A) and proportional (P). They were referred to as: R1A, R2A, R3A, 
R1P, R2P, R3P, S3A, and S3P, and corresponded to eight sets of 100 simulated datasets to be 
analysed. Note that for the sparse design only sets with γ = 3, the most non-linear model, were 
evaluated. 
4.2. Estimations 
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4.2.1. Initial conditions 
The same model from which the simulated datasets were generated was used for 
estimation. Each dataset was analysed twice: (i) with true initial conditions, i.e. starting 
estimate values set to the original parameter values on which simulations were based, and (ii) 
with altered initial conditions: γ set to 1, the other fixed effects to two fold of their true value, 
and random effects to low numbers (Table 1). This procedure explored the robustness of the 
approaches. 
4.2.2. Software settings 
Estimation algorithms were mostly utilised with the default settings with which they are 
available in the different studied software. Changes from these defaults were listed Table 2 
and reported below. 
FOCE and LAPLACE in NONMEM 7.1.0 (FOCE_NM and LAP_NM) had the maximum 
number of iterations set to the highest possible value as done in common practice, and the 
option INTERACTION was added for the scenarios with a proportional error. FOCE in 
R 2.9.1 (FOCE_R) was using the nlme routine. LAPLACE and AGQ in SAS 9.2 (LAP_SAS 
and AGQ_SAS) were adaptive Gaussian quadrature respectively corresponding to a number 
of quadrature points (QPOINTS) of 1 and 9. Other settings listed in table 2 were adapted from 
the defaults (FTOL=1E-15.7 XTOL=0 TECH=QUANEW EBSTEPS=50 EBSUBSTEPS=20 
EBSSFRAC=0.8 EBTOL=2.2E-12 INSTEP=1) in SAS. These settings were used previously 
(22) to improve robustness in the conditional modes calculations (the EB options) or to reduce 
the very high default convergence criteria (for FTOL and XTOL). 
SAEM presents a number of settings the user is invited to modify, that can follow different 
terminologies depending on the software: NONMEM 7.1.0/MONOLIX 3.1. These include the 
numbers NBURN/K1 and NITER/K2 of iterations in the stochastic (k = 1) and the cooling 
(decreasing k) phases, respectively, as well as the number ISAMPLE/nmc of chains in the 
MCMC procedure. Stopping rules can also be defined for the two software for the stochastic 
phase, and also for the cooling phase in MONOLIX only. A simulated annealing version of 
SAEM during the first iterations can be set in NONMEM while it is automatically performed 
in MONOLIX. Moreover, i can be defined as the log-transform of a Gaussian random vector 
to meet with constraints of positivity, which corresponds to mu-referencing in NONMEM and 
the default in MONOLIX. In light of these possibilities, SAEM was run with each software 
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twice: once with the default settings (SAEM_NM and SAEM_MLX), and a second time with 
modified settings (SAEM_NM_tun and SAEM_MLX_tun). SAEM_NM was run with the 
defaults NITER=1000, ISAMPLE=2 and IACCEPT=0.4, and with the number of iterations 
from the stochastic phase NBURN≤2000 being stopped with a convergence test for 
termination CTYPE=3 based on objective function, fixed effects, residual error and all 
random effect elements. SAEM_NM_tun had parameters linearly mu-referenced, decreased 
number of iterations in the two phases and increased number of individual samples. 
Concerning the convergence, it was stopped in the same manner as SAEM_NM, but instead 
of every 9999 iterations being submitted to the convergence test system, only every 25 were.. 
SAEM_MLX was run with setting the maximal number of iterations for the stochastic 
(K1≤500) and the cooling phase (K2≤200) using the following stopping rules: i) the stochastic 
phase is ended before K1 is reached if an iteration m is met where p(y, ηm; Ψm) < p(y, ηm-
1K1; Ψm-1K1)  with lK1=100 and ii) the cooling phase is ended before K2 is reached if an 
iteration m is met where the variances of the parameters, computed over a window of lK2 
iterations, is reduced by a factor rK2 compared to their values at the end of the stochastic 
phase, with lK2=50 and rK2=0.1. SAEM_MLX_tun was tuned in the way that it had a 
number of iterations for the stochastic phase, K1=500 (i.e. not using the stopping rule for this 
phase), and increased individual samples, nmc=5. 
Hence nine approaches (a = 9) were explored through the estimation of the simulated 
datasets: FOCE_NM, FOCE_R, LAP_NM LAP_SAS, AGQ_SAS, SAEM_NM, 
SAEM_NM_tun, SAEM_MLX, and SAEM_MLX_tun. 
4.3. Computer power 
FOCE, LAPLACE and SAEM run in NONMEM 7.1.0 were assisted with PsN 3.2.5 (37) 
on a Linux cluster node of 3.59 GHz with a G77 Fortran compiler. Estimations with FOCE in 
R were done on a 2.49 GHz CPU as well as some with SAEM in MONOLIX (others were on 
a 1.83 GHz), assisted by a Matlab version R2009b. All SAS runs (LAPLACE and AGQ) were 
performed on a 2.66 GHz computer using SAS 9.2 for Windows. 
5. Performance comparison 
5.1. Completion rates 
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The proportion of completed estimations, i.e. the number K of the 100 analysed datasets 
that produced parameter estimates with each approach was reported. Other computations were 
executed with these Z sets of results; however when less than 50 of the runs completed, 
statistical measures were not produced. Z, thereafter expressed as a percentage, was therefore 
assessing the stability of the different approaches, whereas results were given only when K ≥ 
50. 
5.2. Runtimes 
Runtimes were recorded as the CPU time needed to estimate each of the 100 copies of a 
simulated scenario. Then the average was calculated. A correction was done with the clock 
rate of the processor in the computer on which runs were performed as in (8). Parallelization 
was not possible with the investigated approaches, so did not have to be accounted for. 
K
s ,a s ,a ,k .,ak 1
1
NI CPUt CPUf
K 
    (8) 
where NIs,a is the calculated number of instructions in billions for scenario s with approach 
a, CPUts,a,k the real time in seconds recorded on a CPU to perform the corresponding k
th 
 
estimation, and CPUf.,a the frequency in GHz (equivalent to billion instructions per second) of 
the clock in the utilized CPU. 
5.3. Accuracy and precision 
Relative estimation errors (RER), relative bias (RBias), and root mean squared error 
(RMSE) were computed such that the accuracy and the precision of the estimation algorithms 
were evaluated for each of the 9 components (p) of the vector Ψ. The RER (%) are evaluated 
for each estimate and box-plot of RER(%) show both bias (mean) and imprecision (width). 
The RBias (%) describes the deviation of the mean over the estimated parameters from their 
true value. The relative RMSE (RRMSE %) summarize both the bias and the variability in 
estimates. The Standardized RRMSE (%) was constructed for each parameter and each 
approach as the RRMSE divided by the lowest RRMSE value obtained across all approaches 
for that parameter in (12). 
k *
p ,s ,a p ,s ,.
k p ,s ,a *
p ,s ,.
RER ( ) 100
   
   
  

   (9) 
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K
p ,s ,a k p ,s ,ak 1
1
RBias( ) RER ( )
K 
     (10) 
K 2
p ,s ,a k p ,s ,ak 1
1
RRM SE ( ) RER ( )
K 
     (11) 
 
p ,s ,a
p ,s ,a
a p ,s ,a
RRM SE ( )
Standardized RRM SE ( )
min RRM SE ( )

 

 (12) 
where k
p


 is the estimated p component for the k
th
 data set and Ψp
*
 the true value. 
For each scenario and each approach, mean standardized RRMSE across the 9 components 
of  was computed as a global measure of the performance.  
Computations were conducted in R 2.11.1. 
RESULTS 
1. Completion rates 
100 % of the analyses started from true initial conditions completed with final estimates for 
all the approaches except FOCE_R (99, 62, 5, 69, 32, 2, 16, and 33 % for the R1A, R2A, 
R3A, R1P, R2P, R3P, S3A, and S3P scenarios, respectively) (Figure 2). The same simulated 
datasets estimated with altered starting values gave completion rates of the same order with 
FOCE_R (98, 76, 16, 68, 8, 3, 5, and 10 % for the R1A, R2A, R3A, R1P, R2P, R3P, S3A, and 
S3P scenarios, respectively), decreased ones with SAEM_NM (97, 91, 16, 74, 81, and 75 % 
for the R1A, R3A, R1P, R2P, R3P, and S3P scenarios, respectively) and SAEM_NM_tun (91 
and 67 % for the R3A and S3A scenarios), and maximum completion (100 %) for all the other 
approaches. Therefore 133 sets of estimates were considered for further comparison statistics, 
11 failing to meet the 50 % completion criterion. 
2. Runtimes 
Runtimes expressed as number of instructions (NI) ranged from 4 to 1614 billion 
instructions (BI), and are displayed for estimations starting from true initial conditions in 
Figure 2. FOCE_NM was the fastest approach (median NI = 7.2 BI and 9.6 BI, starting from 
13 
 
 
true and altered initial conditions, respectively), never taking longer than 15 BI, very closely 
followed by FOCE_R and LAP_SAS. LAP_NM was displaying equivalently short runtimes 
for the additive error models (median NI = 10.2 BI and 11.2 BI, starting from true and altered 
initial conditions, respectively), which were doubled (median NI = 22.7 BI and 27.3 BI, 
starting from true and altered initial conditions, respectively) for the proportional error 
models, the design having no noticeable impact. SAEM approaches with default settings were 
systematically slower than FOCE and LAPLACE, but it was faster in MONOLIX (median NI 
= 43.2 BI and 52.6 BI, starting from true and altered initial conditions, respectively) than in 
NONMEM (median NI = 147.7 BI and 287.8 BI, starting from true and altered initial 
conditions, respectively), by around 3 folds when the initial conditions were true and 6 folds 
when they were altered. The tuned version of the approach, SAEM_MLX_tun, took around 
2.5 times longer (median NI = 117.6 BI) than the non-tuned version, whereas 
SAEM_NM_tun (median NI =79.9 BI) was almost 3 times faster than SAEM_NM and 
1.5 times faster than SAEM_MLX_tun; both had very similar runtimes between true and 
altered initial conditions. The NI reached with AGQ_SAS was high (median NI = 674.8 BI 
and 864.1 BI, starting from true and altered initial conditions, respectively); it was 
consistently the slowest. 
3. Accuracy and precision 
Boxplots of RER for ED50 and ω
2
(ED50) estimates are displayed on Figures 3a and 3b as 
they often are the main parameters of interest in dose-response studies. Standardized RRMSE 
star-plots with 9 radii for each of the elements of  are represented in Figure 4; on a given 
radius, the closer to 1, the closer is the performance relative to the approach with the smallest 
RRMSE for the parameter of interest. For a global assessment across parameters, mean 
standardized RRMSE are illustrated in Figure 5. 
3.1. True initial conditions 
As displayed in Figure 3a, the parameter ED50 was globally accurately estimated under true 
conditions, but presented a lower precision for scenarios with γ = 1. The highest and most 
consistent biases were observed with FOCE_R, on the few scenarios for which metrics were 
produced due to poor completion rates. ED50 was better estimated with AGQ_SAS, LAP_NM 
and FOCE_NM on the sparse design than with the other tested approaches, which produced 
some bias, especially LAP_SAS (interquartile range excluding zero), and exhibited 
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imprecision (wide interquartile range and longer whiskers), especially the SAEM approaches 
(except SAEM_NM). For the parameter ω2(ED50) (Figure 3b), estimates were slightly more 
biased, but essentially more imprecise, especially with γ = 1, and the additive error model. For 
the sparse design, most approaches exhibited a bias, except the four SAEM approaches, which 
appeared to provide more accurate but less precise estimates than the other approaches. 
SAEM_NM obtained the lowest RRMSEs whatever the scenario and parameter (values 
available in appendix); as illustrated in Figure 4, when γ > 1 and the error model was additive, 
all approaches but SAEM_NM estimated large Emax, and when γ = 3 and the error model was 
proportional, all approaches but SAEM_NM estimated large ED50. 
Globally on the rich design, as represented Figure 5, all approaches had a mean 
standardized RRMSE below 1.5 for most of the scenarios with the exception of FOCE_R. 
Nevertheless, for scenario R3A, FOCE_NM and SAEM_MLX had it slightly above 1.5. On 
the sparse design, the LAPLACE methods, AGQ_SAS, and SAEM_NM had mean 
standardized RRMSEs below 1.5, whereas SAEM_MLX had it above 1.5 for both error 
models and SAEM_NM_tun and SAEM_MLX_tun for only the S3A scenario. 
3.2. Altered initial conditions 
On the rich design, most of the approaches estimated ED50 similarly as when starting from 
true values, as illustrated in Figure 3a. However, the results of the SAEM approaches changed 
compared to the previous initial conditions case and sometimes drastically for the versions 
with the default settings, even failing to reach 50 % of completion for SAEM_NM with 
scenario R1P. On the sparse design, most of the methods obtained biased estimates, with the 
exceptions of AGQ_SAS, SAEM_NM, and FOCE_NM, which gave the distributions of 100 
estimated ED50 the most centred on the true value and tight. FOCE_R results could not be 
assessed, but the other approaches presented tailed distributions of estimated ED50, with 
quartiles not including the true value for LAP_SAS with both scenarios models and for 
SAEM_MLX with S3A. As shown in Figure 3b, the bias and imprecision in the ω2(ED50) 
estimates were increased by starting from altered initial conditions particularly for 
SAEM_NM, whereas SAEM_MLX_tun yielded the boxplot most centred on zero. 
It can be observed in Figure 4 that FOCE_NM and AGQ_SAS obtained standardized 
RRMSEs below 1.5 on most scenarios and parameters. When the sparse design was adopted 
the SAEM approaches and the LAPLACE approaches obtained standardized RRMSEs above 
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1.5 on most parameters, but for the proportional error model scenario they were below 1.5 
with SAEM_NM_tun. FOCE_R estimated most parameters with poor standardized RRMSE, 
but especially γ and σ. 
On Figure 5, FOCE_NM, and AGQ_SAS are shown to have lowest mean standardized 
RRMSE whatever the scenario, with LAP_SAS and SAEM_MLX_tun having mean 
standardized RRMSE below 1.5 for all but one scenario (S3P and S3A respectively). 
FOCE_R obtained mean standardized RRMSE above 1.5 on all scenarios where its 
performance could be evaluated, whereas SAEM_NM, SAEM_MLX and LAP_NM also 
obtained elevated mean standardized RRMSE on at least half of the scenarios. 
DISCUSSION 
The present work provides a comparison in terms of speed, robustness, bias and precision 
of the most commonly used likelihood-based estimation approaches in nonlinear mixed effect 
modelling for the fitting of a dose-response model. 
FOCE_R was shown to be the least robust approach with less than 50 % completion rate 
on 9 of the 16 combinations of scenarios and initial conditions settings investigated. All other 
approaches could be evaluated as they completed at least half of the data sets, with the 
exception of SAEM_NM in one situation. However the convergence criteria differed across 
estimation methods. In NONMEM, convergence of classical methods (FOCE and LAPLACE) 
is based only on the parameter estimation gradient, whereas it was set to be based on objective 
function, thetas, sigmas, and all omega elements for the SAEM methods. In MONOLIX, the 
automatic stopping rule for the stochastic phase is based on the complete log-likelihood. In 
SAS, convergence is primarily based on 6 key criteria, relating to the absolute and relative 
changes in the likelihood, gradients, and parameter values. The difficulty in defining 
convergence complicates these comparisons.  
The convergence criteria used will affect runtimes, with less strict convergence criteria 
yielding shorter runtimes. However it is believed that the trends would remain the same, with 
the classical methods FOCE and LAPLACE being the fastest, and AGQ being the slowest. 
AGQ slow runtimes were due to the high number of quadrature points chosen (9 quadrature 
points across 3 random effects imply 729 (9
3
) likelihood evaluations for each subject at each 
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iteration). Reducing this (e.g. to 3 quadrature points) would have significantly shortened the 
runtimes, and may have led to similar results (not inspected). Unsurprisingly, the estimation 
process speed was driven by the extent of the likelihood function simplification, with first-
order linearization-based algorithms achieving the shortest run times. Within each iteration, 
the SAEM approaches are faster than the Gaussian quadrature-based method because they 
sample the integrand rather than fully integrating it, but many more iterations are needed with 
SAEM than with AGQ. Increasing the number of chains to the SAEM algorithm was 
additionally time-consuming in MONOLIX, whereas SAEM_NM_tun was overall faster than 
SAEM_NM due to the number of iterations being decreased. 
Globally, the approximation based on a linearization of the model, but for FOCE_R, gave 
good results for the fixed effects (relative biases typically less than 3 %) when starting from 
the true conditions, with ω2(ED50) and Cov(Emax,ED50) being least well estimated. As for their 
precision, it was decreasing in a similar extent using altered conditions and/or on a sparse 
design. The performance of adaptive Gaussian quadrature was high on all cases. The 
conclusions were less straightforward for the SAEM approaches. Indeed, SAEM_NM lacks a 
global search first step in order to refine the initial estimates; this could be appreciated with 
the results of the scenarios starting from altered values compared to SAEM_MLX. . However 
increasing the number of individual samples and linearly mu-referencing the parameters 
substantially improved the results. Mu-referencing appeared to yield more efficient behaviour 
of SAEM_NM_tun according to the implementation of the algorithm in NONMEM. 
SAEM_MLX performance with altered initial conditions comes from the fact that it is 
coupled with a simulated annealing algorithm slowing up the decrease in variance estimates 
during the first iterations allowing escape from the local maxima of the likelihood and 
convergence to a neighbourhood of the global maximum. However, the more reduced the 
information is in the data, the more iterations and the more chains are needed to be provided 
in order to improve the convergence. Of note, on the S3A scenario with altered initial 
conditions, which is a particularly challenging combination of error model, Hill parameter 
value and design, the SAEM_NM_tun performance was improved using a user-supplied 
Omega shrinking algorithm for fixed effects parameters without interindividual variability 
instead of the default gradient process (results not shown). A similar Omega shrinking 
approach is implemented in MONOLIX.  
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One noticeable aspect about the investigated approaches is the possibility for user-defined 
options. The main advantage is the opportunity for the modeller to adapt the search to their 
specific problem. This makes it necessary for the user to be educated to the different 
alternatives, and their need might change during the model building, or worst, their non-
utilization might influence the model selection. Nevertheless, an implementation always 
entails default settings, chosen by the developer and enlightened by common usage. Hence the 
same estimation algorithm existing in distinct software represents a dissimilar approach not 
only because of the implementation, but also because of the defaults settings. For that reason, 
explored approaches were primarily run with the options set to the defaults and secondarily 
with settings changed or tuned, when possible.  
As estimation approaches in NLMEM require the user to provide initial values for the 
parameters to estimate, it was decided to assess the impact of these values on their 
performances. For the sake of simplicity, only two scenarios were considered, with initial 
guesses respectively correct and reasonably altered. The real case scenario would probably lie 
in between both situations as the user would first explore the data at hand, as well as use prior 
knowledge on the compound to come up with reasonable guesses. Of note, low initial values 
for the variances may provide less power to the EM-like algorithms for exploring the 
parameter search space, however in MONOLIX the simulated annealing inflates initial values 
for the variances. 
Models investigated in the present study were dose-response models, based on the most 
commonly used structure in the field, a sigmoid Emax. This model is fairly simple and contains 
a low number of parameters. The degree of nonlinearity is linked to the value of the Hill 
factor, which was varied across scenarios. Non-linearity is the major difficulty for ML 
estimation methods, for the reason mentioned earlier of no closed form solution for the 
integrand, whether the algorithm performs a linear approximation, a numerical integration or 
a stochastic approximation of the likelihood. Decreasing performance could hence be 
observed along the γ-increase with the additive error models, but not with the proportional 
error models, revealing other factors to take into account, such as the design. Models defined 
by ordinary differential equations represent also a challenge for estimation methods, and 
would perhaps result in conclusions of a different nature, but were not investigated in the 
present study. 
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Random effects are keys in the analysis of repeated data, allowing the modeller to quantify 
interindividual variability. The number of random effects that can be included in a model 
primarily depends on the amount of information generated under the chosen design, but also 
on the capacity of the algorithm to estimate them in addition to the fixed effects. The structure 
plays likewise a role, with considerations about the size of the variance-covariance matrices; 
therefore the studied structure included random effects on all parameters except one, plus one 
correlation. 
Studies performing comparisons are bound to be limited by their tools. In the present work 
we used RMSE to sum-up information on both accuracy and precision which is a metric 
known to be sensitive to outliers. Yet, these choices provided us with the opportunity to 
present a readable comparison of 9 different estimation approaches across several 
combinations of true parameter values, error models and designs.  
Drawbacks of FOCE_R experienced in this study had been described before (27). 
Nevertheless, previously reported (22, 24) poor performance of LAP_NM for skewed 
distributions was not as evident in this study, where LAP_NM mean standardized RRMSE 
was low for all scenarios. However parameters on which performance was the poorest were 
variance of random effects, which was the case here also. These studies and additional ones 
(23, 25) showed estimates were improved with the use of AGQ_SAS or SAEM_MLX_tun; 
these approaches gave good results here too. Another investigation (26) highlighted that for 
cases with low information content LAP_NM had problems that disappeared when 
SAEM_NM was used. Again, this was only retrieved for variances of random effects, but was 
accordingly the case for the sparse design scenarios S3A and S3P. The impact of initial 
conditions had not been explored before, and this study showed the lack of robustness of 
some otherwise accurate estimation methods. Notwithstanding, it is important to realize that 
none of the NONMEM nor MONOLIX methods has been tested before, as the sofware have 
been updated since previous publications (from versions NONMEM VI and MONOLIX 2.4, 
respectively). Another comparison (38) presenting EM methods as alternatives to gradient-
based methods in terms of computation rates and runtimes was recently published (based on 
real data). 
CONCLUSIONS  
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For standard dose-response models analyzed through mixed-effects models, differences 
could be identified in the performance of estimation methods available in current software. 
Along with the exploration of different settings, designs and initial conditions, the strength of 
the present investigation resides in the inclusion of a high number of estimation methods and 
software. 
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TABLES: 
Table 1: True initial conditions are the parameter values used for the simulation of 8 scenarios constructed with 3 different Hill factor (γ) 
values and 2 different residual error models: additive (A) and proportional (P). True and altered initial conditions were used for the estimation of 
the simulated datasets. 
 
Parameters E0 Emax ED50 γ ω
2
(E0) ω
2
(Emax) Cov(Emax,ED50) ω
2
(ED50) σ
2
 
True initial 
conditions 
5 30 500 1 2 3 0.090 0.490 0.245 0.490 A: 4 P: 0.010 
Altered initial 
conditions 
10 60 1000 1 1 1 0.100 0.100 0.010 0.100 A: 1 P: 0.0625 
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Table 2: Approach settings changed from defaults 
 
Approach Algorithm Software Settings 
FOCE_NM FOCE NONMEM 7.1.0 
A1, A2, A3: MAXEVALS=9999 
P1, P2, P3: INTERACTION MAXEVALS=9999 
FOCE_R FOCE R 2.9.1 - 
LAP_NM LAPLACE NONMEM 7.1.0 
A1, A2, A3: MAXEVALS=9999 
P1, P2, P3: INTERACTION MAXEVALS=9999 
LAP_SAS LAPLACE SAS 9.2 
QPOINTS=1  FTOL=1E-8 XTOL=1E-8 TECH=QUANEW/DBLDOG EBSTEPS=300 
EBSUBSTEPS=300 EBSSFRAC=0.2 EBTOL=1E-6 INSTEP=1E-1  
AGQ_SAS AGQ SAS 9.2 
QPOINTS=9  FTOL=1E-8 XTOL=1E-8 TECH=QUANEW/DBLDOG EBSTEPS=300 
EBSUBSTEPS=300 EBSSFRAC=0.2 EBTOL=1E-6 INSTEP=1E-1  
SAEM_NM SAEM NONMEM 7.1.0 INTERACTION CTYPE=3  
SAEM_NM_tun SAEM NONMEM 7.1.0 
INTERACTION CTYPE=3  
NBURN=1000 NITER=200 ISAMPLE=5 IACCEPT=0.3 CINTERVAL=25 NOABORT 
SAEM_MLX SAEM MONOLIX 3.1 - 
SAEM_MLX_tun SAEM MONOLIX 3.1 K1=500 nmc=5 
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FIGURES 
Figure 1: Individual response versus dose profiles from a typical dataset simulated using 6 
of the 8 dose-response profiles: rich design, additional error model with Hill parameter = 1, 2 
and 3: R1A, R2A, R3A and proportional error model with Hill parameter = 1, 2 and 3: R1P, 
R2P, R3P. On the x-axis are displayed the four doses considered. 
Figure 2: Percentage of completion and number of instructions (in billions) obtained with 
the 9 investigated approaches for the true initial conditions. The barchart represents the 
median, and the arrows link the minimum to the maximum value of the range.  
Figure 3: Relative estimation error (RER) for the parameter ED50 (3a) and its variance 
(3b), for the 8 scenarios R1A, R2A, R3A, R1P, R2P, R3P, S3A, and S3P referring to 2 
simulation designs (R for rich and S for sparse), 3 Hill factor values (1, 2, 3), and 2 residual 
error models (A for additive and P for proportional), with the estimation from true initial 
conditions and altered initial conditions. The boxplot represents the median (middle bar) and 
the interquartile range (box limits), with points for the mean (black) and the outliers (grey).  
Figure 4: Standardized RRMSE of the 9 population parameters for the 8 scenarios R1A, 
R2A, R3A, R1P, R2P, R3P, S3A, and S3P, and 2 initial conditions: true and altered. The 
following colour code was used: FOCE_NM = red, FOCE_R = pink, LAP_NM = orange, 
LAP_SAS = light green, AGQ_SAS = dark green, SAEM_NM = dark blue, SAEM_NM_tun 
= light blue, SAEM_MLX = dark violet, SAEM_MLX_tun = light violet. 
Figure 5: Strip chart of the mean standardized RRMSE obtained with each approach for 
the 8 scenarios R1A, R2A, R3A, R1P, R2P, R3P, S3A, and S3P, and 2 initial conditions: true 
and altered, on a semi-log scale. The colour code used is described in the Figure 4 legend. The 
star symbol (*) represents the S3A estimate from SAEM_NM_tun that is above 45 units. The 
dashed line is drawn at the value 1.5 used for description purposes in the results section. 
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APPENDIX 
Tables of relative bias (RBias) and relative RMSE (RRMSE) obtained with the 9 investigated approaches for the parameters of the 
explored scenarios (in %) 
(* based on less than 50% convergence) 
True initial conditions 
Parameter E0 Emax ED50 γ ω
2(E0) ω
2(Emax) Cov(Emax,ED50) ω
2(ED50) σ
2 
Approach Scenario RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias 
RRMS
E 
F
O
C
E
_
N
M
 
R1A 1.63 5.13 -0.57 10.99 0.03 20.15 -0.52 6.37 7.38 32.35 -2.49 18.16 -9.83 38.46 -15.46 33.45 -0.89 11.96 
R2A 1.74 4.81 -6.95 11.84 -6.17 10.28 0.11 5.62 6.00 29.21 -1.57 18.42 -24.69 39.95 -22.14 32.06 -2.89 12.29 
R3A 1.64 4.74 -13.71 16.53 -9.55 12.22 0.39 7.66 5.87 27.89 2.24 19.70 -42.16 51.76 -31.55 38.17 -2.09 12.53 
R1P -1.48 3.26 -1.78 10.90 -0.89 19.69 -0.29 5.43 0.34 15.06 -0.99 16.78 -3.45 38.13 -6.24 32.32 -2.34 14.39 
R2P -1.11 3.11 -1.29 8.86 0.70 8.08 -1.76 3.54 0.23 14.80 -1.30 16.97 -5.84 31.32 -1.90 20.92 -4.58 13.84 
R3P -0.93 3.00 -4.05 10.75 -0.63 8.06 -1.77 3.95 0.08 14.34 -0.97 17.19 -14.72 35.46 -6.54 21.27 -4.52 13.61 
S3A 3.52 7.33 -17.30 22.97 -8.14 19.28 1.41 34.15 15.53 60.54 3.59 27.87 -32.83 57.49 -29.76 40.68 -3.55 22.93 
S3P -0.22 3.74 -16.06 21.97 -4.18 17.85 -5.19 12.61 6.37 23.48 9.54 34.88 -19.34 59.31 -17.16 31.49 -18.03 40.40 
F
O
C
E
_
R
 R1A 4.96 6.98 -10.74 17.10 -18.57 38.70 15.82 20.91 -0.67 30.75 -21.33 27.50 -66.19 70.34 -70.68 73.06 35.32 127.65 
R2A* 8.54 10.05 -14.65 18.03 -15.70 20.92 18.47 26.32 2.03 39.61 -28.22 32.73 -88.36 89.42 -78.93 82.41 154.19 413.29 
R3A* -2.14 13.02 -1.00 12.60 -2.87 14.66 0.94 27.16 -34.89 57.34 -17.35 21.90 -74.52 78.89 -38.29 54.30 126.92 260.89 
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L
A
P
_
N
M
 
R1A -0.47 5.03 2.46 15.34 5.08 32.25 0.58 6.89 -0.02 29.61 -7.30 19.46 -15.72 44.51 -10.99 49.31 0.86 12.23 
R2A -0.22 4.56 -1.18 9.30 -1.58 8.74 0.99 5.26 -0.04 28.31 -9.06 19.34 -21.65 39.61 -12.14 23.48 -1.53 13.48 
R3A -1.08 4.92 -5.08 10.11 -1.00 7.03 -1.77 7.26 0.34 22.36 -5.17 17.62 -37.61 51.00 -17.02 25.62 1.71 15.72 
R1P -0.26 2.93 0.53 11.56 0.33 20.85 0.95 5.52 -1.07 15.05 -5.69 17.40 -14.89 38.33 -11.84 33.56 -1.37 15.48 
R2P -0.27 2.90 1.18 9.05 -0.11 7.56 0.46 3.18 -0.61 14.66 -4.07 17.29 -3.91 32.64 -1.98 20.57 -5.15 13.97 
R3P -0.33 3.20 -0.27 9.74 -0.53 8.00 0.23 3.80 -1.01 14.34 -2.42 15.72 -10.16 34.28 -5.38 19.31 -4.44 14.57 
S3A -1.04 7.11 -3.72 14.19 3.34 12.11 -9.11 12.55 3.68 40.75 0.62 32.50 -37.50 51.45 -18.37 23.76 3.69 25.13 
S3P 0.41 4.72 -1.77 15.57 6.52 13.60 -5.66 11.21 3.22 23.50 -0.33 21.80 -43.69 50.37 -21.66 26.83 8.86 50.11 
L
A
P
_
S
A
S
 
R1A -0.47 5.03 2.49 15.38 5.01 32.04 0.60 6.86 -0.25 29.45 -7.36 19.46 -16.00 43.75 -11.25 48.47 0.88 12.25 
R2A -0.52 4.79 1.27 9.45 0.89 10.10 -0.25 4.79 -1.71 25.12 -8.15 17.78 -14.78 31.65 -6.67 21.06 -0.92 12.68 
R3A -0.21 4.70 -0.28 11.75 2.61 10.70 -2.00 6.37 -1.06 26.56 -10.39 19.13 -32.57 45.96 -10.73 24.43 0.17 13.48 
R1P -0.27 2.95 0.49 11.55 0.23 20.83 1.00 5.54 -1.10 15.06 -5.72 17.44 -15.00 38.47 -11.97 33.45 -1.37 15.48 
R2P -0.18 2.94 1.19 9.23 0.17 8.32 0.42 3.16 -0.83 14.66 -5.33 17.30 -5.99 31.44 -2.59 19.83 -4.08 13.98 
R3P -0.34 2.83 0.44 9.60 -0.40 7.23 0.26 3.61 -0.77 13.85 -1.35 17.76 -4.08 34.40 -3.23 19.50 -4.72 14.81 
S3A -1.12 6.95 2.58 14.31 9.42 15.61 -10.39 13.19 1.41 36.17 1.55 21.97 -29.74 36.00 -13.36 20.88 4.71 21.49 
R1P -0.97 3.07 6.71 17.45 23.32 48.30 -6.23 8.60 -8.21 17.35 -30.02 34.28 -99.49 102.36 -97.68 97.73 94.80 97.36 
R2P 0.19 2.97 -13.86 15.57 -15.68 16.45 12.02 12.62 -2.85 14.74 -15.82 20.80 -51.26 54.71 -32.47 35.48 11.41 19.78 
R3P* 0.47 3.26 -16.19 17.98 -17.11 17.97 18.97 20.34 -1.32 14.55 -17.94 24.05 -68.42 70.72 -35.67 39.09 13.34 24.66 
S3A* 6.22 9.06 -5.38 30.51 -21.05 35.48 677.60 945.82 17.41 66.82 -28.44 40.55 -101.02 105.63 -59.24 67.61 2.73 32.73 
S3P* 1.01 4.99 -15.53 30.94 -33.27 42.94 731.17 1075.08 -2.95 23.51 -22.89 37.89 -103.73 109.53 -55.19 61.62 11.01 118.97 
34 
 
 
S3P 0.45 3.75 3.79 16.22 12.86 17.73 -6.97 10.11 2.09 20.64 4.91 22.05 -28.65 36.24 -16.53 23.39 7.00 53.67 
A
G
Q
_
S
A
S
 
R1A -0.55 5.00 2.40 12.94 3.26 23.81 0.16 6.66 1.44 32.20 -0.96 19.05 2.31 43.67 1.37 38.78 -0.68 11.70 
R2A -0.46 4.51 -0.99 10.37 -1.95 9.02 1.11 5.43 0.03 28.85 -4.90 18.49 -13.55 33.20 -9.33 24.53 0.35 12.42 
R3A 0.12 4.51 -1.67 9.92 0.56 9.57 0.36 6.38 -3.13 27.35 -15.44 21.97 -34.94 44.47 -11.91 24.26 4.28 14.47 
R1P -0.23 2.93 2.61 12.55 3.84 22.86 0.07 5.55 -0.32 14.99 -0.30 17.47 3.08 42.84 3.18 37.17 -1.31 14.21 
R2P -0.17 2.94 1.52 9.17 0.24 8.31 0.30 3.12 -0.65 14.39 -2.48 17.24 -1.98 30.26 -1.35 19.53 -1.80 13.74 
R3P -0.21 2.95 0.41 8.86 -0.56 7.21 0.54 3.26 -0.78 13.86 -3.44 17.98 -5.96 32.17 -3.40 17.93 -1.00 13.79 
S3A -2.99 12.24 0.31 11.34 -2.22 9.27 0.26 4.05 -13.01 25.19 -32.48 40.06 -17.04 24.74 -6.46 19.36 -99.61 99.61 
S3P -1.82 19.45 6.54 22.53 -4.63 12.58 0.35 3.94 -18.01 33.80 -65.20 75.15 -31.74 38.39 -3.42 23.98 57.63 90.29 
S
A
E
M
_
N
M
 
R1A -0.14 4.95 1.70 9.10 2.11 21.52 1.06 6.43 -0.63 30.16 -1.49 17.60 -6.80 40.47 -5.55 36.99 -1.93 11.32 
R2A -0.33 4.59 -1.67 5.03 -1.03 6.56 1.36 5.22 0.75 29.06 -1.01 19.12 -5.00 36.72 -3.59 24.85 -2.87 12.32 
R3A -0.40 4.32 -1.53 4.15 -0.40 5.24 1.26 6.48 0.66 28.06 -0.26 20.72 -3.68 39.52 -2.26 23.27 -2.48 12.40 
R1P -0.60 3.00 0.19 9.71 -0.74 18.04 1.35 5.31 1.01 15.16 -1.43 16.51 -5.98 35.69 -4.96 28.34 -3.62 13.97 
R2P -0.88 2.87 -1.80 7.54 1.09 7.51 0.72 3.10 1.13 14.78 -1.35 16.71 -3.48 31.37 -1.29 20.59 -5.67 14.12 
R3P -1.11 2.74 -4.26 7.58 -0.45 4.92 1.40 3.70 1.01 14.40 -1.82 17.56 -9.51 33.60 -4.44 18.87 -5.36 13.52 
S3A -1.91 6.66 -2.20 8.12 -2.02 8.93 0.67 14.45 24.83 55.69 9.07 33.25 13.59 55.81 5.40 29.88 -17.51 25.81 
S3P -0.52 3.60 -8.09 12.46 -4.23 11.15 3.90 12.33 3.18 19.29 4.41 31.15 -7.71 48.44 -3.94 26.12 -32.42 43.16 
S
A
E
M
_
N
M
_
tu
n
 
R1A -0.11 5.02 3.77 14.61 6.45 29.38 -0.66 5.94 0.67 32.81 0.91 18.72 7.59 47.92 8.07 48.14 -0.63 11.79 
R2A 0.24 4.49 2.79 12.09 1.36 11.51 0.54 5.69 -0.51 30.20 0.77 21.68 6.77 48.50 4.68 33.93 -0.87 12.61 
R3A 0.08 4.36 2.78 13.04 0.87 10.40 0.55 6.50 -0.66 29.43 0.95 21.84 5.35 47.65 2.13 29.55 -0.38 12.66 
35 
 
 
R1P -0.20 2.97 0.97 10.48 -0.11 17.06 0.87 5.05 0.72 15.13 -0.43 17.11 -0.47 39.34 -0.01 32.32 -1.70 13.81 
R2P -0.14 2.92 1.98 9.54 0.54 8.64 0.18 3.24 0.56 14.74 -0.88 17.26 1.83 32.56 1.72 21.70 -2.09 13.85 
R3P -0.14 2.89 1.26 9.79 -0.17 7.50 0.61 3.58 0.46 14.16 -0.66 18.66 -0.18 35.97 -0.48 20.96 -2.16 11.79 
S3A -0.89 6.76 2.64 25.12 2.04 23.22 1.46 18.73 11.57 61.74 4.01 39.87 1.06 76.93 -1.46 42.43 -5.56 23.73 
S3P -0.29 3.84 --2.02 22.47 -2.62 19.92 4.44 15.50 1.27 19.29 3.02 35.38 -4.08 70.33 -3.11 35.04 -17.02 41.06 
S
A
E
M
_
M
L
X
 
R1A -2.06 5.78 -0.59 10.56 -4.07 18.01 1.99 6.54 13.57 36.46 -3.50 19.29 -5.49 42.68 -7.45 35.85 -0.12 11.71 
R2A -1.18 5.01 -1.02 10.45 -2.91 10.29 2.22 6.50 8.24 31.83 -4.07 21.02 -8.17 41.25 -6.95 29.33 0.14 12.78 
R3A -1.02 4.60 -2.54 12.32 -3.34 10.68 4.06 9.14 8.29 30.44 -4.59 21.71 -14.26 46.70 -9.95 30.44 -0.29 12.55 
R1P -0.23 2.92 0.67 10.69 0.16 19.35 0.85 5.17 -0.67 15.06 -2.60 19.17 -5.98 44.60 -5.68 36.92 3.36 15.48 
R2P -0.17 2.92 0.83 8.58 -0.57 8.00 0.81 3.13 -0.66 14.35 -3.63 17.86 -3.16 32.41 -1.50 21.87 0.92 13.91 
R3P -0.15 2.87 -0.96 9.34 -1.63 7.61 1.64 4.28 -0.87 14.10 -4.62 18.18 -9.95 33.47 -5.54 20.49 1.84 14.08 
S3A -2.46 7.41 0.58 23.75 -1.69 19.48 4.08 20.19 29.33 63.33 7.75 40.63 6.29 81.81 -2.28 42.53 -8.02 21.48 
S3P -0.36 3.73 11.02 55.84 6.86 47.15 2.69 17.51 -1.74 19.71 11.86 46.28 20.70 94.21 6.06 46.89 3.72 49.86 
S
A
E
M
_
M
L
X
_
tu
n
 
R1A -0.82 5.11 1.29 11.91 0.73 23.18 0.96 6.77 2.44 34.61 -1.59 18.66 0.01 41.45 -1.54 35.32 -0.84 12.06 
R2A -0.66 4.54 1.87 11.54 -0.07 10.81 0.79 5.70 1.56 31.83 -0.78 20.46 3.07 45.56 0.94 31.82 -0.81 12.68 
R3A -0.67 4.46 1.44 12.44 -0.45 10.16 1.15 6.86 1.99 29.58 -0.69 21.79 0.48 47.55 -1.49 30.01 -0.84 12.49 
R1P -0.23 2.93 0.18 10.99 -1.43 20.58 1.66 5.58 -0.27 14.96 -1.94 16.67 -3.16 38.18 -2.72 34.39 -1.70 14.33 
R2P -0.21 2.93 2.15 9.24 0.56 8.31 0.24 3.08 -0.43 14.54 -0.98 17.02 3.00 33.31 1.64 22.25 -2.34 13.85 
R3P -0.19 2.91 1.81 9.65 0.10 7.52 0.54 3.63 -0.57 14.05 -0.81 18.93 1.36 35.55 -0.36 20.16 -1.91 13.34 
S3A -0.52 6.60 -4.31 23.01 -5.20 19.73 9.81 26.69 6.04 59.23 1.80 34.56 -10.17 75.57 -10.86 44.62 -3.18 24.42 
36 
 
 
S3P -0.26 3.69 -3.07 19.79 -3.23 18.85 5.21 16.58 -1.08 18.82 0.08 34.03 -10.32 70.22 -7.14 35.41 -8.14 40.60 
37 
 
 
Altered initial conditions 
Parameter E0 Emax ED50 γ ω2(E0) ω2(Emax) Cov(Emax,ED50) ω2(ED50) σ
2 
Approach Scenario RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE RBias RRMSE 
F
O
C
E
_
N
M
 
R1A 1.63 5.13 -0.58 10.99 0.03 20.15 -0.52 6.37 7.38 32.34 -2.49 18.16 -9.83 38.45 -15.46 33.46 -0.89 11.96 
R2A 1.78 4.83 -6.87 11.41 -5.97 10.06 0.07 5.54 4.62 30.68 -2.01 18.91 -25.52 41.17 -21.97 31.49 -2.34 13.72 
R3A 1.96 4.79 -12.43 16.81 -8.55 13.84 -0.40 8.44 -9.43 44.90 1.54 20.76 -40.11 51.28 -29.23 41.32 5.06 23.16 
R1P -1.48 3.26 -1.77 10.90 -0.88 19.69 -0.30 5.42 0.34 15.06 -0.99 16.78 -3.44 38.13 -6.23 32.32 -2.33 14.39 
R2P -1.11 3.11 -1.30 8.86 0.69 8.42 -1.75 3.53 0.21 14.61 -1.38 16.60 -5.57 31.44 -1.86 21.42 -4.52 13.83 
R3P -1.04 3.24 -4.77 11.04 -0.85 8.31 -1.58 4.07 0.17 14.64 -0.51 18.56 -16.44 39.32 -7.57 22.18 -3.88 13.24 
S3A 3.65 7.44 -9.31 42.25 1.22 42.62 -0.46 31.62 28.61 76.36 -4.71 32.37 -44.01 65.80 -31.73 42.56 -4.69 23.95 
S3P 0.09 3.91 -16.15 23.52 -3.44 19.55 -3.74 12.84 6.44 24.51 4.00 34.50 -32.25 63.83 -22.93 35.53 -2.81 73.12 
F
O
C
E
_
R
 
R1A 4.72 7.07 -12.82 17.49 -23.35 35.69 18.36 22.33 -4.00 34.44 -20.29 25.49 -64.71 68.87 -67.53 69.46 20.23 33.43 
R2A 3.88 9.61 -11.59 16.41 -14.86 19.91 11.95 22.78 -26.19 79.81 -26.75 31.55 -86.84 88.13 -80.61 83.50 
187.9
7 
397.65 
R3A* -3.04 8.94 -1.31 21.84 -1.07 27.15 -7.75 26.73 -83.34 98.60 -37.80 49.80 -84.06 86.33 -77.98 86.15 
691.8
1 
1112.98 
R1P -0.84 3.07 6.31 17.97 22.74 48.93 -5.83 8.60 -8.64 17.31 -30.72 34.97 -100.41 103.20 -97.42 97.50 94.51 97.42 
R2P 0.26 2.98 1.77 151.33 6.79 217.18 11.30 13.29 -3.50 15.14 -16.98 22.95 -51.65 55.73 -32.80 36.63 20.49 67.16 
R3P* 0.53 3.38 -19.12 20.54 -19.40 20.20 19.81 21.18 -1.95 21.04 -13.93 23.77 -66.40 68.55 -38.89 41.70 32.06 104.63 
S3A* 6.22 9.06 -5.38 30.51 -21.05 35.48 677.60 945.82 17.41 66.82 -28.44 40.55 -101.02 105.63 -59.24 67.61 2.73 32.73 
S3P* 1.01 4.99 -15.53 30.94 -33.27 42.94 731.17 1075.08 -2.95 23.51 -22.89 37.89 -103.73 109.53 -55.19 61.62 11.01 118.97 
38 
 
 
L
A
P
_
N
M
 
R1A -0.46 5.04 2.45 15.18 4.82 30.76 0.57 6.89 -0.05 29.57 -7.30 19.33 -15.94 43.35 -10.85 49.63 0.78 12.27 
R2A 1.87 5.44 0.20 16.14 1.23 17.72 0.12 8.12 -54.95 72.69 -14.45 22.82 -29.58 46.14 -9.63 27.02 22.51 36.47 
R3A 2.56 8.55 -4.27 18.76 1.40 22.35 -6.57 12.53 -73.81 84.79 -11.09 30.42 -45.75 69.37 -7.11 48.06 52.26 82.30 
R1P -0.25 2.93 0.52 11.56 0.28 20.83 0.97 5.52 -1.10 15.06 -5.68 17.38 -14.95 38.40 -11.87 33.53 -1.37 15.48 
R2P -0.09 3.31 2.20 10.90 1.20 13.27 0.09 3.83 -0.55 17.55 -5.45 18.85 -6.96 40.12 0.87 23.31 -0.35 24.88 
R3P 0.26 4.39 0.66 11.29 0.69 10.96 -0.74 4.33 -0.99 15.83 -5.65 20.82 -16.73 41.72 -2.88 23.77 4.32 30.93 
S3A -1.48 7.22 5.96 40.16 24.23 56.27 -12.45 27.20 60.31 130.05 7.94 52.58 -65.45 90.29 -38.47 47.62 10.24 39.45 
S3P 1.60 4.72 12.50 44.25 23.79 50.97 -12.11 22.05 -9.65 36.82 -5.13 48.06 -62.17 82.82 -33.69 38.80 
202.6
7 
273.31 
L
A
P
_
S
A
S
 
R1A -0.45 5.03 2.91 16.34 6.13 35.18 0.50 6.98 -0.07 29.50 -7.17 19.65 -14.84 44.99 -9.53 51.43 0.83 12.26 
R2A -0.01 4.68 3.73 11.01 4.11 12.92 -0.10 5.29 -3.70 28.94 -9.97 20.66 -13.22 36.58 -1.34 24.99 3.39 17.13 
R3A -0.64 4.67 0.57 12.93 3.28 13.99 -2.80 7.23 0.72 26.14 -10.64 24.12 -32.81 46.54 -12.80 26.76 -1.45 13.99 
R1P -0.26 2.93 0.53 11.56 0.32 20.84 0.96 5.52 -1.09 15.06 -5.67 17.37 -14.90 38.35 -11.84 33.56 -1.36 15.48 
R2P -0.22 2.93 2.01 10.14 0.76 9.24 0.28 3.18 -0.79 14.54 -5.22 17.99 -3.41 35.32 -0.43 22.77 -3.89 15.05 
R3P -0.11 2.90 4.60 13.16 3.23 10.31 -0.95 3.99 -0.10 14.52 -4.05 22.75 0.57 44.16 2.20 23.59 1.53 21.41 
S3A -2.18 8.12 19.53 36.01 30.58 48.86 -17.24 22.16 46.03 94.45 9.77 36.94 -27.82 57.47 -21.78 31.10 13.51 34.97 
S3P 0.41 4.31 15.96 28.63 26.55 38.58 -15.40 18.89 -7.11 29.38 0.32 35.53 -32.54 49.92 -24.43 30.38 
104.2
0 
186.10 
A
G
Q
_
S
A
S
 
R1A -0.55 5.00 2.40 12.94 3.26 23.81 0.16 6.66 1.44 32.20 -0.96 19.05 2.31 43.67 1.37 38.78 -0.68 11.70 
R2A -0.05 4.84 2.43 11.31 2.20 12.83 0.47 5.45 -1.71 30.06 -7.01 21.30 -9.10 35.94 -0.56 28.76 1.74 14.32 
R3A 0.02 4.40 -1.58 12.82 0.80 11.89 0.55 7.66 -0.94 28.96 -15.25 24.56 -37.08 51.40 -13.26 28.15 3.32 13.90 
R1P -0.23 2.93 2.61 12.55 3.84 22.86 0.07 5.55 -0.32 14.99 -0.30 17.47 3.08 42.83 3.18 37.17 -1.31 14.21 
39 
 
 
R2P -0.19 2.92 1.97 9.19 0.70 8.35 0.16 3.09 -0.46 14.63 -2.63 16.72 -0.33 32.26 0.52 21.91 -1.81 13.70 
R3P -0.02 2.97 3.77 12.44 2.41 9.86 -0.23 3.50 -0.48 14.78 -6.10 19.27 -3.42 36.21 0.57 21.55 5.88 20.99 
S3A -0.05 6.73 -8.40 25.45 -1.23 26.59 1.01 14.56 10.03 67.90 -17.26 33.84 -71.92 77.29 -42.69 46.51 8.89 27.75 
S3P 0.35 3.94 -1.82 19.45 6.54 22.53 -4.63 12.58 -3.42 23.98 -18.01 33.80 -65.20 75.15 -31.74 38.39 57.63 90.29 
S
A
E
M
_
N
M
 
R1A -0.22 5.20 59.29 62.94 35.68 52.65 -4.67 8.26 8.01 31.20 38.20 50.00 77.94 129.89 77.44 135.55 -5.63 12.32 
R2A -3.63 6.74 41.77 244.10 60.37 653.79 -6.84 12.23 20.14 42.11 49.78 140.05 142.50 367.92 94.60 239.33 -1.37 19.24 
R3A -8.60 10.65 113.94 309.40 34.62 273.44 -28.84 32.14 6.30 39.11 436.02 683.44 962.02 1443.49 510.96 755.94 34.12 54.28 
R1P* 5.53 10.62 72.60 121.03 -15.84 37.16 -8.08 25.06 13.63 27.76 4589.61 
18105.3
3 
-4456.81 
17451.4
8 
1128.65 4210.09 14.02 51.81 
R2P 3.76 5.73 4.97 15.30 -4.74 10.73 -0.08 3.23 3.55 16.71 8.38 39.15 8.34 34.41 5.81 23.12 -4.50 13.47 
R3P 7.57 10.65 -0.72 11.42 -12.79 16.79 0.64 3.46 11.31 27.21 3.63 25.96 -0.49 36.41 6.17 22.75 -4.17 13.94 
S3A -8.98 13.46 11.81 28.44 -4.16 36.74 -13.00 22.77 107.50 152.96 83.26 158.77 175.66 311.97 84.32 145.58 -26.92 33.45 
S3P -21.77 4.18 -36.70 20.81 -31.61 17.01 -18.04 17.88 227.99 19.67 2690.59 27.43 -496.72 65.03 -12.60 36.78 -11.33 39.69 
S
A
E
M
_
N
M
_
tu
n
 
R1A -0.46 5.11 4.47 14.02 7.40 27.11 -1.14 6.01 1.77 33.44 1.65 19.95 10.81 49.32 10.87 46.02 -0.87 11.73 
R2A -0.81 4.71 5.30 14.39 3.25 13.54 -0.86 5.94 2.51 31.05 3.82 22.66 17.14 55.94 11.22 39.52 -0.83 12.21 
R3A -1.07 4.77 4.60 13.82 1.81 10.33 -1.33 6.92 3.17 29.27 2.90 23.49 12.92 51.19 6.56 30.41 -0.02 12.20 
R1P -0.22 2.95 5.58 13.60 10.04 25.38 -1.58 5.77 0.85 15.11 3.08 19.25 13.69 49.33 13.57 41.51 -1.32 14.13 
R2P -0.22 2.95 3.04 10.14 1.64 9.03 -0.25 3.29 0.70 14.69 0.50 17.65 6.37 35.07 4.36 23.47 -2.50 13.63 
R3P -0.19 2.90 2.95 10.60 0.92 8.07 -0.09 3.35 0.57 14.13 1.18 19.15 5.87 37.92 2.28 21.45 -1.93 13.23 
S3A -3.47 8.41 1857.98 6896.95 837.51 2788.61 -14.48 29.54 13.44 71.67 187.72 535.79 342.45 877.83 148.92 361.69 0.26 27.96 
S3P -0.86 3.91 13.39 32.55 10.57 29.49 -3.68 14.50 2.52 19.80 12.15 43.05 28.56 85.23 16.08 43.03 -17.22 42.87 
40 
 
 
S
A
E
M
_
M
L
X
 
R1A -1.62 5.75 9.38 16.67 18.83 38.00 -3.93 8.11 7.94 34.90 2.95 23.34 22.21 61.89 22.37 54.02 0.80 12.58 
R2A -1.91 5.26 11.00 19.46 9.42 20.98 -3.98 8.74 6.12 32.38 9.27 30.38 36.53 77.77 23.47 52.22 0.93 13.18 
R3A -2.00 4.98 14.78 26.80 8.78 19.48 -6.25 11.04 4.15 30.33 21.59 53.35 53.40 112.68 23.77 53.14 2.89 13.26 
R1P -0.26 2.96 19.56 26.88 49.55 75.31 -7.56 10.84 -1.55 15.67 7.46 26.07 33.37 77.62 31.24 67.52 11.48 27.02 
R2P -0.18 2.91 2.30 9.91 0.86 9.21 0.27 3.75 -0.69 14.65 -0.91 18.86 3.29 38.72 1.73 23.64 0.67 15.04 
R3P -0.11 2.90 1.16 10.20 -0.36 7.65 1.25 4.28 -0.80 13.94 -1.46 20.27 -0.72 40.47 -1.47 22.47 0.16 13.49 
S3A -7.30 10.39 132.11 185.95 137.19 184.09 -34.04 37.15 70.51 114.85 80.32 123.52 165.84 251.64 81.00 132.09 6.50 28.62 
S3P -1.10 4.18 47.54 95.87 39.74 83.43 -9.14 22.28 -1.16 21.37 37.18 83.16 79.36 162.95 36.93 78.15 25.72 88.55 
S
A
E
M
_
M
L
X
_
tu
n
 
R1A -0.84 5.05 2.81 12.91 3.75 24.24 -0.07 6.89 2.26 33.38 -0.01 19.65 6.18 48.68 4.01 41.45 -0.77 11.87 
R2A -0.55 4.67 2.36 12.33 0.47 11.80 0.69 6.11 1.10 32.10 -0.10 22.08 4.99 49.20 2.15 32.91 -0.72 12.65 
R3A -0.71 4.41 3.43 14.40 1.04 11.73 0.17 7.55 1.42 29.51 1.71 25.12 7.33 54.26 2.04 30.42 -0.35 12.77 
R1P -0.24 2.94 3.02 13.34 4.81 26.59 0.09 5.96 -0.29 15.01 0.55 17.69 6.19 45.83 5.64 41.55 -1.14 14.50 
R2P -0.16 2.94 1.98 9.30 0.37 8.42 0.42 3.19 -0.48 14.53 -0.99 17.09 2.63 33.48 1.39 22.07 -2.11 13.68 
R3P -0.16 2.90 1.62 9.57 -0.07 7.32 0.73 3.60 -0.61 14.02 -1.00 18.98 0.86 35.46 -0.64 20.44 -1.57 13.34 
S3A -2.25 6.88 30.60 58.87 27.27 55.13 -11.26 23.25 10.74 67.76 29.30 71.63 61.71 139.04 29.45 68.79 -1.29 23.44 
S3P -0.50 3.69 6.59 30.63 5.30 29.08 1.07 16.58 -1.34 18.92 3.12 39.15 6.11 79.49 3.60 39.80 -5.11 41.58 
 
